Clinical Trial Update: Analysis of Patients Treated for Chronic Granulomatous Disease Since January 1, 1995

View source ↗

Summary

This document presents a completed analysis of patients treated for Chronic Granulomatous Disease since January 1, 1995.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulomatous Disease

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Chronic Granulomatous Disease | Status: COMPLETED